438190-90-0 Usage
General Description
2,5-dichloro-1H-imidazo[4,5-b]pyridine is a chemical compound with a molecular formula C7H4Cl2N2. It is a potentially hazardous industrial chemical and a known mutagenic and carcinogenic agent. 2,5-dichloro-1H-imidazo[4,5-b]pyridine is used in the manufacturing of various industrial and agricultural products, and its exposure may occur through inhalation, ingestion, or skin contact. Research has shown that 2,5-dichloro-1H-imidazo[4,5-b]pyridine has been associated with adverse health effects, including respiratory and skin irritation, as well as potential long-term health risks such as cancer and developmental toxicity. Therefore, proper handling and safety measures should be taken when dealing with this chemical to minimize its harmful effects on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 438190-90-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,8,1,9 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 438190-90:
(8*4)+(7*3)+(6*8)+(5*1)+(4*9)+(3*0)+(2*9)+(1*0)=160
160 % 10 = 0
So 438190-90-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Cl2N3/c7-4-2-1-3-5(10-4)11-6(8)9-3/h1-2H,(H,9,10,11)
438190-90-0Relevant articles and documents
Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines
-
, (2008/06/13)
Substituted spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
